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Abstract
Injuries to articular cartilage result in the development of lesions that form on the surface of the cartilage.
Such lesions are associated with articular cartilage degeneration and osteoarthritis. The typical injury
response often causes collateral damage, primarily an effect of inflammation, which results in the spread of
lesions beyond the region where the initial injury occurs. We present a minimal mathematical model based
on known mechanisms to investigate the spread and abatement of such lesions. In particular we represent
the “balancing act” between pro-inflammatory and anti-inflammatory cytokines that is hypothesized to be
a principal mechanism in the expansion properties of cartilage damage during the typical injury response.
We present preliminary results of in vitro studies that confirm the anti-inflammatory activities of the
cytokine erythropoietin (EPO). We assume that the diffusion of cytokines determine the spatial behavior
of injury response and lesion expansion so that a reaction diffusion system involving chemical species
and chondrocyte cell state population densities is a natural way to represent cartilage injury response.
We present computational results using the mathematical model showing that our representation is
successful in capturing much of the interesting spatial behavior of injury associated lesion development and
abatement in articular cartilage. Further, we discuss the use of this model to study the possibility of using
EPO as a therapy for reducing the amount of inflammation induced collateral damage to cartilage during
the typical injury response. The mathematical model presented herein suggests that not only are anti-
inflammatory cytokines, such as EPO necessary to prevent chondrocytes signaled by pro-inflammatory
cytokines from entering apoptosis, they may also influence how chondrocytes respond to signaling by
pro-inflammatory cytokines.
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Articular cartilage is composed of cells known as chondrocytes. Mechanical stress and injury is known to
kill (via necrosis) chondrocytes and results in the formation of lesions on the cartilage surface [1–4]. The
limited capacity of chondrocytes to self-repair, together with certain aspects of the typical injury response
such as inflammation, can cause the spread of lesions and development of osteoarthritis. Recent research
[5] suggests that inflammatory cytokines such as tumor necrosis factor α (TNF-α) play a significant role
in causing the spread of cartilage lesions. Anti-inflammatory cytokines such as erythropoietin (EPO)
play an antagonistic role to TNF-α, limiting the area over which a lesion can spread by counteracting
some of the effects of inflammation [5]. Moreover, the authors in [5] describe the potential use of EPO
as a therapy for cartilage injury and lesion abatement
The potential for EPO to suppress catabolic and inflammatory responses of chondrocytes to various
alarmins, i.e. molecules that trigger the innate immune response, was explored in a cell culture model
(Figure 1). Bovine articular chondrocytes in serum-free culture were pre-treated with EPO and then
exposed to alarmins in the form of cell lysates or the 29 kDA fibronectin fragment (Fn-f). Interleukin-1β
(IL-1β) was used as a control. Cell lysates were made by repeated freeze-thawing of excess cells from
the same culture. Culture media were collected for immunoblot analysis of matrix metalloproteinase-3
(MMP-3) and A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAMTS-5). Cell
layers were extracted for analysis of nuclear factor κB (NF-κB) and inducible nitric oxide synthases
(iNOS). The results revealed that lysates, Fn-f, and IL-1β induced NF-κB phosphorylation (Figure 1A).
Fn-f, and IL-1β but not lysates also induced iNOS, MMP-3 and ADAMTS-5 expression (Figure 1B,C,D).
In the case of NF- B, EPO treatment blocked activation by lysates, but not by Fn-f or IL-1 . EPO also
dramatically reduced iNOS, MMP-3, and ADAMTS-5 expression in response to Fn-f and IL-1β. These
results underscore the ability of EPO to counter injury effects on multiple pathways.
Figure 2 illustrates the balance between pro-inflammatory (e.g. TNF-α) and anti-inflammatory (e.g.
EPO) cytokines during the typical injury response. Damage due to chemical or mechanical stress initiates
production of alarmins, such as damage associated molecular pattern molecules (DAMPs) [5–7]. These
alarmins trigger production of pro-inflammatory cytokines such as TNF-α by cells near the initial injury
site (see (b) in figure 2) [5]. Thus there is a penumbra ((c) in figure 2) of “sick” cells formed at the
boundary of the initial injury as a result of inflammation. While still viable, these cells are at risk of
3Figure 1: Effects of EPO on chondrocyte responses to alarmins and IL-1β. Immunoblot
analyses are shown for phospho- and total nuclear factor kappa-B (NF-kB), a pro-inflammatory tran-
scription factor (A), inducible nitric oxide synthase (iNOS), a catabolic signaling factor (B), matrix
metalloproteinase-3 (MMP-3) (C), and a disintegrin and metalloproteinase domain with thrombospondin
repeats (ADAMTS-5) (D), which cause cartilage matrix degeneration. Primary cultures of bovine chon-
drocytes (1 x 106 cells/well) were treated with 10 IU/ml EPO for 24 hours, then challenged for an
additional 24 hours with the indicated concentrations of purified 29 kDa fibronectin fragment, a known
extracellular matrix DAMP, or interleukin-1b (IL-1b), a pro-inflammatory cytokine, or cell lysates con-
taining multiple cellular DAMPS. EPO treatment suppressed catabolic responses induced by all three
treatments.
dying themselves due to the presence of the pro-inflammatory cytokines, resulting in the spread of injury
as shown in (d)-(e) in figure 2. However, cells far enough from the injury are able to produce anti-
inflammatory cytokines such as EPO to check the spread of injury and promote healing. This is shown
(d∗)-(e∗) in figure 2. It is also suggested in [5] that TNF-α acts in such a way to limit EPO signaling. Thus
there is a critical balance between pro-inflammatory and anti-inflammatory cytokines which determines
the spreading properties of an articular cartilage lesion associated with injury. Moreover, the authors
in [5] suggest that introduction of exogeneous EPO at an early time after an initial injury could be an
effective therapy for minimizing the amount of collateral damage to cartilage that occurs as a result of
inflammation.
The goal of this work is to study via mathematical modeling the EPO/TNF-α interaction described
4Figure 2: Injury response. When a wound occurs DAMPs promote production of TNF-α (b), an
initially viable penumbra (yellow in (c)) of cells becomes EPOR active. These cells are in danger of death
which can result in the spread of injury as seen on the left in (d) and (e). However, EPO can counteract
the effects of TNF-α and prevent spread of the lesion (d∗) and (e∗).
above. Herein we develop a model capable of simulating the scenario illustrated in figure 2. Moreover,
the model is developed as a potential for studying the use EPO or other anti-inflammatory cytokines as
a therapy for lesion abatement. The type of model, and in particular the one described below, in this
article is of value as it provides a link between observed phenomena and the mechanisms involved in
driving that phenomena. Models such as those presented below can also help to generate hypotheses and
suggest experiments or fundamental quantities to be measured. More practically, mathematical modeling
such as we use in this paper could provide quick and inexpensive initial screening of potential therapies.
Models
In this section we describe the mathematical model developed to represent the biological interactions of
chondrocytes and cytokines described in [5]. We aim for a minimal model based on known mechanisms
considered to be the dominant factors in articular cartilage lesion abatement. By a minimal model
we mean one in which the removal of any component results in behavior that is inconsistent with the
typical injury responses in cartilage as discussed in [5]. We note that the model described below can
be expanded or modified to include further interactions as new results from experiment and observation
dictate. In particular, further chemical pathways such as interleukin-1 β IL1-β can easily be incorporated
if necessary. The chemical species included below are chosen for their functionality, that is their action on
chondrocytes during injury response. Hence they can be replaced with any other chemical species whose
5Figure 3: States of chondrocytes during stereotypical injury response. Healthy cells (C) become
sick. Typically a healthy cell will first become catabolic (ST ) and either enter apoptosis (DA), or become
EPOR active (SA). EPOR active cells may be saved by EPO to become healthy once again, or die
(apoptosis).
effects on chondrocytes are functionally the same. The chondrocyte cell states described below represent
the biological actions of the cells in response to signaling by a particular cytokine during the typical
injury response. These actions are assumed to be analogous to those of other cell types, for which aspects
of innate immune response, such as local inflammation considered in this paper, are well established.
We consider a population of chondrocytes fixed in matrix, which is typical of articular cartilage. Sub-
populations of chondrocytes are assumed to exist in different states corresponding to the chemical signals
being received by the cells during injury response. Figure 3 shows the states in which subpopulations of
chondrocytes may exist. We refer to the normal state of a subpopulation of chondrocytes as the healthy
state. We denote by C the population density (cells per unit area) of healthy chondrocytes at a given time
and location. As a result of inflammation and injury healthy chondrocytes can enter into a “sick” state.
Cells in this state are at risk death (via apoptosis) unless their signaling by TNF-α is somehow limited.
We consider two subpopulations of cells in the sick state. We denote by ST the population density of cells
in the “catabolic” state. Catabolic cells are chondrocytes that have been signaled by alarmins and are
capable of synthesizing TNF-α and other cytokines associated with inflammation. Healthy cells signaled
by DAMPs or TNF-α enter into the catabolic state and begin to synthesize TNF-α and produce reactive
oxygen species (ROS). Catabolic cells that are signaled by TNF-α express a receptor (EPOR) for EPO
and make up the subpopulation of sick cells we refer to as EPOR active. It should be noted that there
is a time delay of 8–12 hours before a cell expresses the EPO receptor after being signaled to become
EPOR active [5]. We denote the population density of EPOR active cells by SA. Since EPOR active cells
express a receptor for EPO, they may switch back to the healthy state if signaled by EPO. However, as
discussed in [5] TNF-α limits production of EPO. Thus there is a balance between EPO and TNF-α that
6Figure 4: Signaling involved in cartilage injury response. The occurrence of an injury begins
a sequence of chemical productions that promote the inflammatory response. Lysing (necrotic) cells
give off DAMPs (M) resulting in a population of catabolic cells that produce TNF-α (F ) and ROS
(R). ROS promotes production of EPO (P ) by healthy cells while TNF-α acts to block EPO signaling.
Furthermore, TNF-α degrades extracellular matrix providing another source of DAMPs. The cells switch
state according to the signaling by chemicals produced in response to injury and inflammation. DAMPs
and TNF-α drive the C → ST transition, TNF-α drives the ST → SA transition, while TNF-α and
DAMPs drive the ST → DA transition. Finally, EPO drives the SA → C transition. This figure
illustrates the assumptions of the mathematical model ((3) below). Not shown: DAMPs given off as a
result of matrix degradation also influences the switch from healthy to catabolic.
determines the spreading behavior of cartilage lesions. The catabolic and EPOR active cells together
make up the population of cells forming the penumbra as illustrated in figure 2. We also consider a
“dead” state for subpopulations of chondrocytes. This includes necrotic cells DN and apoptotic cells DA.
We note that for the purposes considered herein that apoptotic cells do not feed back into the system
and thus are not explicitly represented in the mathematical model. We assume chondrocytes become
necrotic only at the time of an initial injury. Necrotic cells release alarmins such as DAMPs that initiate
the injury response. Either catabolic or EPOR active cells become apoptotic if signaled by inflammatory
cytokines.
Figure 4 details the chemical signaling and the switching of chondrocyte cell states represented in the
mathematical model presented in the following. An initial injury creates a population of necrotic cells
which release alarmins (such as DAMPs) [6,7]. We denote by M the concentration of DAMPs at a given
time and location. The DAMPs signal healthy cells near the injury to enter the catabolic state resulting
7in the production of TNF-α. We denote the concentration of TNF-α at a given time and location by F .
The inflammatory cytokine TNF-α has several effects on the system: It
1. feeds back to continue to switch healthy cells into the catabolic state,
2. causes catabolic cells to enter the EPOR active state [5],
3. influences apoptosis of catabolic and EPOR active cells,
4. degrades extracellular matrix (denoted by U) which results in increased concentrations of DAMPs,
5. has a limiting effect on production of EPO [5].
Catabolic cells also produce reactive oxygen species (ROS) which influences the production of EPO by
healthy cells. We denote the concentration of ROS at a given time and location by R. There is a time
delay of 20–24 hours before a healthy cell signaled by ROS will begin to produce EPO.
In developing a mathematical model to represent the scenario described above we assume that the
chemicals diffuse throughout a domain. This diffusion is essential in determining the spatial behavior,
i.e. the expansion or abatement of the lesion. Since the chondrocytes are fixed in the matrix we do
not consider cell motility. First the mathematical model contains four equations (one for each chemical
species) describing the dynamics of the chemical concentrations. These equations are each of the form:
change in concentration of particular chemical
= diffusion of that chemical
+ production of that chemical by cells in appropriate states
− natural decay of that chemical. (1)
Next the model consists of four equations for the population densities of cells in the healthy, catabolic,
EPOR active, and necrotic states. Each of these equations are of the form:
change in population density of particular cell state
= population density of cells switching into that state due to appropriate signaling
− population density of cells switching out of that state due to appropriate signaling. (2)
8Finally there is an equation corresponding to the degradation of extracellular matrix by TNF-α which
feeds back into the production of DAMPs.
The model equations for the concentrations of the chemical species are:
∂tR =∇ · (DR∇R)− δRR+ σRST , (3a)
∂tM =∇ · (DM∇M)− δMM + σMDN + δUU F
λF + F
, (3b)
∂tF =∇ · (DF∇F )− δFF + σFST , (3c)
∂tP =∇ · (DP∇P )− δPP + σPC(t− τ2) R(t− τ2)
λR +R(t− τ2)
Λ
Λ + F
. (3d)
The equation describing matrix degradation by TNF-α is:
∂tU =− δUU F
λF + F
. (3e)
We note that the right hand side of this equation appears in (3b) as part of the production of DAMPs
as we have assumed that degraded matrix releases alarmins.
The equations for the switching of cell states are:
∂tC =αSA
P
λP + P
− β1C M
λM +M
H(P − Pc)− β2C F
λF + F
H(P − Pc), (3f)
∂tST =β1C
M
λM +M
H(P − Pc) + β2C F
λF + F
H(P − Pc)− γST (t− τ1) F (t− τ1)
λF + F (t− τ1)
− νST F
λF + F
M
λM +M
, (3g)
∂tSA =γST (t− τ1) F (t− τ1)
λF + F (t− τ1) − αSA
P
λP + P
− µSASA
F
λF + F
, (3h)
∂tDN =− µDNDN . (3i)
In (3f) and (3g) the function H(·) is given by
H(s) =
 1 if s < 0,0 if s ≥ 0. (4)
The constant Pc represents a critical level of EPO above which the effects of DAMPs and TNF-α on
9healthy cells is limited.
Based on the diagram in figure 4 and the assumptions underlying that diagram, one could assume
that the function H(·) is identically one, i.e. H ≡ 1. However, if we take H ≡ 1 then figure 4 implies,
and computational results confirm, that there is infinite feedback into the system by alarmins, TNF-
α, and catabolic cells. As noted in [5] “the pro-inflammatory arm of the injury response is inherently
self-amplifying”. This does not allow for lesion abatement or limitation of secondary pro-inflammatory
cytokine induced injury described in [5]. This suggests that signaling by anti-inflammatory cytokines such
as EPO not only promote the switch from the EPOR active state to the healthy state but also influences
the response of healthy cells to alarmins and pro-inflammatory cytokines. Thus the mathematical model
suggests that in some way the anti-inflammatory cytokines limit the switch from the healthy state to the
catabolic state so that there is not an infinite feedback into the system by alarmins, TNF-α, and catabolic
cells. This is consistent with the observation of Brines and Cerami on the antagonistic relationship
between TNF-α and EPO, that “each is capable of suppressing the biological activity of the other” [5].
In the model equations (3) we take the function H(·) as in (4) for convenience. However, there may be
a more appropriate form for the function H(·) that must be determined through experiment to discover
the nature of the effects that sufficient concentrations of EPO or other anti-inflammatory cytokines have
on healthy chondrocytes.
We note some features of the mathematical model 3:
1. we have incorporated the time delays for activation of the EPO receptor and synthesis of EPO
(3d),(3g),(3h),
2. it requires a concentration of TNF-α and DAMPs together for apoptosis of catabolic cells (see (3g)),
3. after some time necrotic cells decay to an inert state (see (3i)) so that there is not a continuous
production of DAMPs for all time from the initial injury. This also corresponds to the loss of
cartilage such as is sometimes associated with osteoarthritis.
The specific functional forms appearing in the model system (3) have been chosen to capture the critical
thresholds and represent the function shapes qualitatively.
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Results and Discussion
Using the mathematical model (3) we can simulate the two scenarios depicted in figure 2. That is,
we can choose parameter values that correspond first to the case where inflammation is not limited by
the presence of anti-inflammatory cytokines (d) and (e) in figure 2 and second to the case where anti-
inflammatory cytokines limit the development of secondary inflammation induced injury (d∗) and (e∗)
in figure 2. For the computations and simulations we assume a two dimensional dimensional domain.
Moreover, as depicted in figure 2 we assume circular symmetry so that changes only occur in the radial
direction. In order to simulate the injury response we obtain numerical approximations to the system
of partial differential equations (3). This is done by discretizing the system in the spatial terms using a
standard finite difference scheme appropriate for circular symmetry. This results in a system of delay-
differential equations which are solved in MATLAB using the dde23 code for solving delay-differential
equations. For details on the methods and software for solving delay-differential equations see [8–10].
First, using the mathematical model (3) we simulate the evolution of chondrocyte population density
(per area, and assuming circular symmetry, as a function of radius) over a period of ten days after an
initial cartilage injury. This corresponds to the cascade of events illustrated in the left hand arrows of
figure 2. The initial conditions correspond to the presence of an initial injury, i.e. a population of necrotic
cells occupying a circle of radius 0.25 mm.
Following the initial injury there is a quick and steady increase in the population density of catabolic
and EPOR active cells and decline in the population density of healthy cells (figures 5(b)-5(i)). After ten
days there has formed a thick penumbra of catabolic cells which are beginning to die off (via apoptosis,
see figure 5(i)) showing that without the presence of EPO there is unlimited secondary pro-inflammatory
cytokine-induced injury and unabated spread of the cartilage lesion. This corresponds qualitatively well
with the expected results illustrated in figure 2 (d),(e).
Figure 6 shows the time evolution of chondrocyte population density (per area, and assuming circular
symmetry, as a function of radius) over a period of ten days after an initial cartilage injury with the
antagonistic effects of EPO on TNF-α. The initial conditions are the same as previously described for
the simulations without EPO. The dynamics of the chondrocyte cell states population densities are the
same over the first day or so as in the case with no EPO. This is due to the time delays for cells to
become EPO producing and EPOR active. However, we see by day 3 or so (see figure 6(d) and compare
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with 5(d)) there is a significant difference in the population dynamics compared with that in the no EPO
case. We begin to see a reversion of cells in the EPOR active state back to the healthy state. While
there is still some amount of secondary injury due to the inflammatory process and presence of pro-
inflammatory cytokines, there is a fixed radius (see figures 6(f)-6(i)) beyond which the penumbra, and
hence the lesion and secondary pro-inflammatory cytokine induced injury, cannot expand. Thus there is
lesion abatement by the action of the anit-inflammatory cytokine EPO. This corresponds qualitatively
well with the expected results illustrated in figure 2 (d∗),(e∗).
Based on the biological assumptions summarized in the diagram shown in figure 2 we have developed a
mathematical representation of some of the principal features of the injury response in articular cartilage.
In particular we have captured, qualitatively, secondary pro-inflammatory cytokine induced injury and
lesion based on the balance between TNF-α and EPO as described in Brines and Cermani [5]. This mod-
eling effort suggests that anti-inflammatory cytokines may act in such a way as to influence the response
of chondrocytes to alarmins and pro-inflammatory cytokines. In particular sufficient concentrations of
anti-inflammatory cytokines may limit healthy chondrocytes conversion to the catabolic state. Provided
dosages, dosage responses, delivery method, etc. the model (3) can be applied to study the effectiveness
of the introduction of exogenous EPO as a potential therapy for limiting secondary pro-inflammatory
cytokine induced injury and promoting healing in articular cartilage. We note however, that due to the
time delays for cells to become EPOR active, there is little or no response to EPO at early times after an
injury has occurred. Thus there is a window of time during which introduction of tissue-protective EPO
derivatives such as discussed in [5] are ineffective as therapies. This is evidenced by comparing figures
5(a)-5(b) with figures 6(a)-6(b) in which there is little or no difference between the case with EPO and
the case without. The model presented herein also has potential applications for studying other issues
related to post-traumatic stress in articular cartilage. By coupling this model with mechanical models, or
including geometric features of cartilage one may be able develop a more complete theoretical description
of aspects of cartilage injury of relevance in the biomedical sciences.
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(a) t=0 (b) t=1.25 days (c) t=2.5 days
(d) t=3.75 days (e) t=5 days (f) t=6.25 days
(g) t=7.5 days (h) t=8.75 days (i) t=10
Figure 5: Healthy and Penumbra cells without EPO. This figure shows the evolution of the healthy
and penumbra (comprised of both catabolic and EPOR active) cell population densities over a period
of 10 days. The results shown here correspond to a situation in which there is no production of or
response to EPO. We see here that the healthy cell population is decimated. In accord with figure 4 and
the corresponding mathematical model (3) this is due to the uninhibited influence of pro-inflammatory
cytokines.
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(a) t=0 (b) t=1.25 days (c) t=2.5 days
(d) t=3.75 days (e) t=5 days (f) t=6.25 days
(g) t=7.5 days (h) t=8.75 days (i) t=10
Figure 6: Healthy and Penumbra cells with EPO. This figure shows the evolution of the healthy
and penumbra cell population densities over a period of 10 days. Initially there is the development of
a population of penumbra cells (6(c)) due to the time lags for EPO production and EPOR activation.
However, once healthy cells at the edge of the penumbra begin to produce EPO and penumbra cells
become EPOR active there is an increase in the population density of healthy cells near the injury and
there ceases to be expansion of the penumbra (figures 6(d) - 6(i)).
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